Evidence map›Paper›PMID 26303085›Full record

ReviewBest practice & research. Clinical endocrinology & metabolism2015

Overlapping nongenomic and genomic actions of thyroid hormone and steroids.

Stephen R Hammes, Paul J Davis

Open access · hybridAbstract readReview
In one paragraph

Review in Best practice & research. Clinical endocrinology & metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Age-related changes of human brain metabolism.European journal of nuclear medicine and molecular imaging · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Is Melanoma Progression Affected by Thyroid Diseases?International journal of molecular sciences · 2022
    Review
  17. Article
  18. Review
  19. Review
  20. Thyroid Diseases and Breast Cancer.Journal of personalized medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Stephen R HammesDivision of Endocrinology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY, USA.
Paul J DavisDepartment of Medicine, Albany Medical College, Albany, NY, USA; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA. Electronic address: pdavis.ordwayst@gmail.com.
Albany Medical Center Hospital · USUniversity of Rochester · US

Funding

Paxillin as a Liaison between Extranuclear and Intranuclear Steroid SignalingR01GM101709 · NIGMS · UNIVERSITY OF ROCHESTER · PI HAMMES, STEPHEN R. · 2013 to 2016
$1.2M
NIGMS NIH HHS R01 GM101709
6 · The paper itself

Abstract

The genomic actions of thyroid hormone and steroids depend upon primary interactions of the hormones with their specific nuclear receptor proteins. Formation of nuclear co-activator or co-repressor complexes involving the liganded receptors subsequently result in transcriptional events-either activation or suppression-at genes that are specific targets of thyroid hormone or steroids. Nongenomic actions of thyroid hormone and steroids are in contrast initiated at binding sites on the plasma membrane or in cytoplasm or organelles and do not primarily require formation of intranuclear receptor protein-hormone complexes. Importantly, hormonal actions that begin nongenomically outside the nucleus often culminate in changes in nuclear transcriptional events that are regulated by both traditional intranuclear receptors as well as other nuclear transcription factors. In the case of thyroid hormone, the extranuclear receptor can be the classical "nuclear" thyroid receptor (TR), a TR isoform, or integrin αvβ3. In the case of steroid hormones, the membrane receptor is usually, but not always, the classical "nuclear" steroid receptor. This concept defines the paradigm of overlapping nongenomic and genomic hormone mechanisms of action. Here we review some examples of how extranuclear signaling by thyroid hormone and by estrogens and androgens modulates intranuclear hormone signaling to regulate a number of vital biological processes both in normal physiology and in cancer progression. We also point out that nongenomic actions of thyroid hormone may mimic effects of estrogen in certain tumors.

Indexed as

Genome, HumanSignal TransductionAnimalsHumansReceptors, SteroidReceptors, Thyroid HormoneSteroidsThyroid HormonesTranscriptional ActivationReceptors, SteroidReceptors, Thyroid HormoneSteroidsThyroid HormonesandrogenestrogengenomicintegrinMAPKnongenomicpaxillinphosphorylationthyroid

Identifiers

PMID26303085
PMCPMC4976293
OpenAlexW2036204980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.